Archive: European Medicines Agency

Showing 311 to 320 of 575 entries

	Title
2011-03-17	Recommendations issued for 2011/2012 seasonal flu vaccine composition Author (Corporate): European Medicines Agency Series Details: News 17.3.11 Published: 17/03/2011 (Last update: 17/03/2011)
2011-03-16	Press Release: European Medicines Agency and US Food and Drug Administration announce pilot program for parallel assessment of Quality by Design applications Author (Corporate): European Medicines Agency Series Details: Press Release EMA/197051/2011 (16.3.11) Published: 16/03/2011 (Last update: 16/03/2011)
2011-02-18	European Medicines Agency reviews further data on narcolepsy and possible association with Pandemrix Author (Corporate): European Medicines Agency Series Details: Press Release 18.2.11 Published: 18/02/2011 (Last update: 18/02/2011)
2011-02-07	New version of EudraGMP allows access to information from all Member States Author (Corporate): European Medicines Agency Series Details: News 7.2.11 Published: 07/02/2011 (Last update: 07/02/2011)
2011-01-20	Press Release: European Medicines Agency recommends approval of new medicine for Cushing’s disease Author (Corporate): European Medicines Agency Series Details: Press Release EMA/CHMP/48737/2012 (20.1.12) Published: 20/01/2011 (Last update: 20/01/2011)
2011-01-20	Press Release: European Medicines Agency recommends suspension of marketing authorisations for meprobamate-containing medicines in the European Union Author (Corporate): European Medicines Agency Series Details: Press Release EMA/CHMP/49123/2012 (20.1.12) Published: 20/01/2011 (Last update: 20/01/2011)
2011-01-20	Press Release: European Medicines Agency starts review of Gilenya (fingolimod) Author (Corporate): European Medicines Agency Series Details: Press Release EMA/CHMP/48716/2012 (20.1.12) Published: 20/01/2011 (Last update: 20/01/2011)
2011-01-01	International workshop: Meeting report. Draft reflection paper on ethical and GCP aspects of clinical trials of medicinal products for human use conducted in third countries and submitted in marketing-authorisation to the EMA, London, 6-7 September 2011 Author (Corporate): European Medicines Agency Published: 2011 (Last update: 01/01/2011)
2011-01-01	Reflection paper on stem cell-based medicinal products Author (Corporate): European Medicines Agency Published: 2011 (Last update: 01/01/2011)
2011-01-01	Report to the European Commission on companies and products that have benefited from any of the rewards and incentives in the Paediatric Regulation and on the companies that have failed to comply with any of the obligations in this Regulation, covering the year 2010 Author (Corporate): European Medicines Agency Published: 2011 (Last update: 01/01/2011)